MAXCYTE, INC.
A cell-engineering company with a platform for developing cell-based therapeutics.
MXCT | US
Overview
Corporate Details
- ISIN(s):
- US57777K1060 (+2 more)
- LEI:
- 54930053YHXULRFCU991
- Country:
- United States of America
- Address:
- 9713 KEY WEST AVENUE,, 20850 ROCKVILLE
- Website:
- https://www.maxcyte.com/
Description
MaxCyte, Inc. is a cell-engineering company that provides enabling platform technologies to advance the discovery, development, and commercialization of cell-based therapeutics. Its core offering is the ExPERT™ platform, which utilizes proprietary Flow Electroporation® technology for efficient, scalable, and non-viral transfection of complex cells. This technology supports a wide range of applications, including cell therapy, gene editing, antibody and protein production, and vaccine development. Additionally, MaxCyte offers SeQure™ genotoxicity assessment services to evaluate the safety of gene-edited products by detecting on- and off-target effects. The company employs a partnership-driven licensing model to support clients from early-stage research through to clinical and commercial manufacturing.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2017-04-13 15:00 |
Notice of AGM and 2016 Annual Report and Accounts
|
English | 17.4 KB | ||
| 2017-03-31 14:40 |
Results of Placing
|
English | 28.7 KB | ||
| 2017-03-31 09:00 |
Proposed Placing to raise up to approx. £20.0m
|
English | 169.7 KB | ||
| 2017-03-20 08:00 |
Full Year Results
|
English | 349.5 KB | ||
| 2017-03-14 08:00 |
CRISPR THERAPEUTICS/CASEBIA COMMERCIAL LICENSE
|
English | 25.0 KB | ||
| 2017-03-02 08:00 |
MaxCyte to Present Pre-Clinical CARMA Data at AACR
|
English | 19.3 KB | ||
| 2017-03-01 08:00 |
Notice of Full Year Results
|
English | 17.0 KB | ||
| 2016-12-21 08:00 |
MaxCyte Announces Collaboration to Advance CARMA
|
English | 18.7 KB | ||
| 2016-12-06 10:34 |
Issue of Equity from exercise of Share Options
|
English | 17.4 KB | ||
| 2016-10-27 09:00 |
Result of Annual General Meeting
|
English | 16.6 KB | ||
| 2016-10-21 09:43 |
Director/PDMR Shareholding
|
English | 29.3 KB | ||
| 2016-09-28 20:00 |
Grant of Options
|
English | 15.8 KB | ||
| 2016-09-27 09:00 |
Financial Results for Six Months ended 30 June 16
|
English | 265.4 KB | ||
| 2016-09-19 19:00 |
Notice of AGM
|
English | 16.5 KB | ||
| 2016-09-06 09:00 |
Notice of Interim Results
|
English | 16.1 KB |
Automate Your Workflow. Get a real-time feed of all MAXCYTE, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for MAXCYTE, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for MAXCYTE, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
